To enhance the quality of life for cancer patients by providing standardization and guidelines for the selection of anticancer agents, we developed “Polaris”, an immune anticancer drug sensitivity testing platform
“Polaris” is an innovative platform capable of testing third-generation anticancer drugs (Immunotherapy drugs) as well as first- and second-generation anticancer drugs
Polaris
Co-culture of organoids and immune cells derived from patient samples
Control
- Control
Test
Figure 1. Images(20x) of tumor organoids
treated with anticancer drugs
- Anti-cancer drug A
- Anti-cancer drug B
- Anti-cancer drug C
- Anti-cancer drug D
- Anti-cancer drug E
- Anti-cancer drug F
- Anti-cancer drug G
- Anti-cancer drug H
- Anti-cancer drug I
- Anti-cancer drug J
- Anti-cancer drug K
- Anti-cancer drug L
Drug screening test
